Abstract

In late June 2009, we set up a dedicated flu-like illness outpatient consultation in the Infectious Diseases and Tropical Medicine department of Marseille university hospital to detect the new A/H1N1 pandemic influenza and to contain efficiently the A/H1N1 infected patients. For 3 months, we compiled data corresponding to a total of 307 patients who presented with a flu-like syndrome. 31 of them were positive for H1N1 pandemic flu through real-time RT-PCR (rRT-PCR); among them, 19 were positive for a rapid influenza detection test (RIDT). We report here the significant clinical characteristics of A/H1N1 pandemic flu patients compared with other flu-like illnesses, which were used to improve the predictive value of the diagnosis in the current epidemiological situation. We found that regardless of the prevalence of A/H1N1 positive cases in the suspected patients, the absence of cough rejects the diagnosis of A/H1N1 infection in 100% of cases. Among patients referred for flu-like illness, those with cough should be tested for A/H1N1 by RIDT. In the current situation, the PPV and NPV of RIDT for H1N1 reached 90.5% and 95.8 %, respectively. It is important to notice that the 2 RIDT-positive that were negative for H1N1 were seasonal H3N2 influenza indicating that specificity and PPV of RIDT for all influenza was 100%. Therefore, positive RIDT does not require rRT-PCR confirmatory test. Only negative RIDT should be tested with rRT-PCR assay. Respecting this algorithm would have saved up to 70,000 Euros ( 100.000 USD) for the 307 patients and would have resulted in a significant gain of time to transmit the laboratory results to the clinical ward.

Highlights

  • On April 15 and 17, 2009 the US CDC identified two cases of a new A/H1N1 influenza virus characterized by a unique combination of gene segment from avian, human and swine origin

  • For 3 months, we compiled data corresponding to a total of 307 patients who presented with a flu-like syndrome. 31 of them were positive for H1N1 pandemic flu through real-time RT-PCR; among them, 19 were positive for a rapid influenza detection test (RIDT)

  • We report here the significant clinical characteristics of A/H1N1 pandemic flu patients compared with other flu-like illnesses, which were used to improve the predictive value of the diagnosis in the current epidemiological situation

Read more

Summary

Introduction

On April 15 and 17, 2009 the US CDC identified two cases of a new A/H1N1 influenza virus characterized by a unique combination of gene segment from avian, human and swine origin. Since the WHO declared that a pandemic with the new H1N1 2009 virus was underway. The rapid influenza diagnostic test (RIDT) have been evaluated with a sensitivity of 40-69% depending upon the trade mark and the viral load of the collected sample [2]. The specificity, the PPV and the NPV were evaluated to be 93%, 77%, 94% respectively when compared to real-time Reverse Transcriptase PCR (rRT-PCR)[3]. The lack of sensitivity of RIDT led to the recommendation to use rRT-PCR test to confirm A/H1N1 pandemic flu diagnosis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call